Mutagenesis
Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer
Published in Cancer Weekly, April 20th, 2004
According to a study from the United States, "hCDC4, the gene that encodes the F-box protein responsible for targeting cyclin E for ubiquitin-mediated proteolysis, has been found to be mutated in a number of primary cancers and cancer-derived cell lines. We have observed that functional inactivation of hCDC4 does not necessarily correlate with elevated levels of cyclin E in tumors. Here we show, however, that hCDC4 mutation in primary tumors correlates strongly with loss of cell cycle regulation of cyclin E."
"Similarly, a breast carcinoma-derived cell line mutated for hCDC4...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-04-20)
More Articles from Cancer Weekly
- Bladder Cancer
Intra-arterial chemotherapy relieves symptoms of advanced bladder cancer - Oncogenesis
Group of proteins can turn cancer on or off, depending on circumstances - Endometrial Cancer
Active lifestyle reduces risk of most common gynecologic malignancy - Enzymology
Matrix metalloproteinase-8 plays a key role in cancer metastasis - Obesity Survival & Mortality
Obesity increases risk of many cancers - Adverse Drug Effects
Flutamide produces liver toxicity and a death in Germany - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
